Significant movement in price has been observed in Virinchi Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Virinchi Limited has submitted their response.
VIRINCHI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE flagged a sharp movement in Virinchi Limited's share price and asked the company for an explanation under SEBI LODR rules. The company replied on July 12, 2025, saying it has no undisclosed price-sensitive information or any event that has not already been reported. Virinchi used the response to restate its four business segments and FY2025 numbers: SaaS Lend-Tech (QFund, revenue ₹133.38 Cr, EBIT ₹19.84 Cr), Hospitals in Hyderabad (revenue ₹104.15 Cr, EBIT ₹-0.88 Cr), US Data Centre/IT services (revenue ₹57.30 Cr, EBIT ₹18.59 Cr), and India Fintech vCard (revenue ₹6.31 Cr, EBIT ₹-3.33 Cr). Management noted that the company's bundled structure causes confusion about whether it is a lend-tech, IT, or healthcare play, and that each segment could potentially be valued at peer levels. The company affirmed it will continue disclosing material developments as required.
This is a routine regulatory clarification, not a negative event — no UPSI was found and no penalty or investigation is mentioned. However, the lack of a clear fundamental trigger for the price move means volatility may persist. The detailed segment restatement could improve analyst understanding and support a re-rating if the market starts valuing each vertical separately.